The Journal of thoracic and cardiovascular surgery · 2025
Cardiopulmonary effects of vasopressin versus norepinephrine in patients undergoing cardiac surgery: A single-center, cluster-randomized crossover trial.
СтатьяРандомизированное исследованиеСравнительное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Geube Mariya, Abraham Abey, Kelava Marta, Bustamante Sergio E, Alfirevic Andrej, Assaad Sherif, Shah Karan, Maldonado Yasdet, Zhang Kan, Hohlfelder Benjamin, Malackany Natasha, Wakefield Brett, Pettersson Gosta B, Tong Michael Z, Sessler Daniel, Skubas Nikolaos, Duncan Andra
Аннотация
BACKGROUND: Laboratory research suggests that vasopressin restores systemic arterial pressure without significantly increasing pulmonary artery pressures, compared with norepinephrine. We therefore tested the hypotheses that treatment of intraoperative vasoplegia with vasopressin rather than norepinephrine induces less pulmonary hypertension and improves right ventricular function during cardiac surgery.
METHODS: Our single-center, cluster-randomized multiple crossover trial enrolled patients undergoing elective cardiac surgery who developed systemic hypotension (mean arterial pressure <70 mm Hg) and cardiac index >2.2 L/min/m2. Randomization was performed in 1-week blocks (total of 46 weeks) where vasopressin or norepinephrine were assigned as the initial vasopressor. Our primary outcome was the time-weighed average mean pulmonary artery pressure to systemic mean arterial pressure ratio and our secondary outcome was right ventricular free wall strain by transesophageal echocardiography, both measured between start and end of chest closure. A predefined subanalysis examined the effect of norepinephrine versus vasopressin in patients with preoperative pulmonary hypertension.
RESULTS: We analyzed 153 patients, 70 assigned to vasopressin and 83 assigned to norepinephrine. There were no significant differences in mean pulmonary artery pressure to systemic mean arterial pressure ratio (0.02; 95% CI, -0.02 to 0.05; P = .646) or in right ventricular free wall strain (3.45%; 95% CI, 0.17% to 6.73%; P = .078) in patients given vasopressin versus norepinephrine infusion. There was no evidence of an interaction between preoperative pulmonary hypertension status and mean pulmonary artery pressure to systemic mean arterial pressure ratio (interaction P value = .781) or right ventricular strain (interaction P value = .780).
CONCLUSIONS: We found no evidence to support the preferential use of vasopressin over norepinephrine in patients undergoing cardiac surgery.
METHODS: Our single-center, cluster-randomized multiple crossover trial enrolled patients undergoing elective cardiac surgery who developed systemic hypotension (mean arterial pressure <70 mm Hg) and cardiac index >2.2 L/min/m2. Randomization was performed in 1-week blocks (total of 46 weeks) where vasopressin or norepinephrine were assigned as the initial vasopressor. Our primary outcome was the time-weighed average mean pulmonary artery pressure to systemic mean arterial pressure ratio and our secondary outcome was right ventricular free wall strain by transesophageal echocardiography, both measured between start and end of chest closure. A predefined subanalysis examined the effect of norepinephrine versus vasopressin in patients with preoperative pulmonary hypertension.
RESULTS: We analyzed 153 patients, 70 assigned to vasopressin and 83 assigned to norepinephrine. There were no significant differences in mean pulmonary artery pressure to systemic mean arterial pressure ratio (0.02; 95% CI, -0.02 to 0.05; P = .646) or in right ventricular free wall strain (3.45%; 95% CI, 0.17% to 6.73%; P = .078) in patients given vasopressin versus norepinephrine infusion. There was no evidence of an interaction between preoperative pulmonary hypertension status and mean pulmonary artery pressure to systemic mean arterial pressure ratio (interaction P value = .781) or right ventricular strain (interaction P value = .780).
CONCLUSIONS: We found no evidence to support the preferential use of vasopressin over norepinephrine in patients undergoing cardiac surgery.